Atreca

NASDAQ BCEL
$0.09 -0.0029 -3.22%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 20 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

3.55M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

-23.73M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

-0.03
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

39.35M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-31.74 %

Upcoming events Atreca

All events
No upcoming events scheduled

Stock chart Atreca

Stock analysis Atreca

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.04 27.22
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.05 3.54
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.44 9.69
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.51 -0.16
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-883.70 13.82

Price change Atreca per year

4.80$ 20.29$
Min Max

Summary analysis Atreca

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Atreca

Revenue and net income Atreca

All parameters

About company Atreca

Atreca, Inc., a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It has a collaboration and license agreement with Xencor, Inc. for research, development, and commercialization of novel CD3 bispecific antibodies in oncology. Atreca, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Address:
450 East Jamie Court, South San Francisco, CA, United States, 94080
Company name: Atreca
Issuer ticker: BCEL
ISIN: US04965G1094
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2019-06-20
Sector: Healthcare
Industry: Biotechnology
Site: https://www.atreca.com

On which stock exchange are Atreca (BCEL) stocks traded?

Atreca (BCEL) stocks are traded on NASDAQ.

What is the ticker of Atreca stocks (BCEL)?

The stock ticker of Atreca’s stocks or in other words, the code is BCEL. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Atreca (BCEL) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Atreca (BCEL) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Atreca (BCEL) stocks traded?

Atreca (BCEL) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Atreca (BCEL) stocks today?

The current price of Atreca stocks on 11.05.2024 is 0.0901 dollars. per share.

What is the dynamics of Atreca (BCEL) stocks from the beginning of the year?

Atreca (BCEL) quotes have increased by -31.06% from the beginning of the year up to 0.0901 dollars. per 1 stocks.

How much did Atreca (BCEL) stocks increase in мае 2024?

This month Atreca (BCEL) quotes have increased by 0.33% to 0.0901 dollars. per share.

How much are Atreca (BCEL) stocks worth?

Today, on October, 11.05.2024 Atreca’s (BCEL) stocks cost 0.0901 dollars..

What is the market capitalization of Atreca (BCEL)?

Capitalization is the market value of Atreca (BCEL) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 11.05.2024, the market capitalization of Atreca (BCEL) is estimated at about 3545841 dollars.